Professor Anirban Basu, the Stergachis Family Endowed Director of the CHOICE Institute, has been appointed as a standing member to serve on the Advisory Council on Financing and Access to Sickle Cell Disease Treatment and Other High-Cost Drugs & Treatments for Governor JB Pritzker of Illinois. Professor Basu co-led the CureSickleCell Initiative’s Cost and Economic Impact Analysis Consortium for NHLBI, culminating in the economic evaluation and value-based pricing of the recently approved gene therapies in sickle cell disease.